Lantus sales are dropping fast because of the competition ... The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba ...

Most insulin-dependent diabetics need to use both a short-acting and long-acting insulin to control their diabetes. "The long-acting insulin is injected once a day to provide a 'ceiling' of ...

November is National Diabetes month, and it’s a great time to raise awareness about diabetes and to learn how to prevent or delay Type 2 diabetes, especially if it runs in your family. Well, let me ...

One wrong move — a little too much insulin or a forgotten dose — and ... risk of hypoglycaemia and partly covering the need ...

the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady access to short-acting insulin. Which insulin brands are in ...

Lawmakers have underscored the importance of steady access to short-acting insulin, which is essential ... a hole’ after Tracy Chapman discovered ‘Fast Car’ mistake Why aren’t we driving ...

However, admission to an intensive care unit to receive intravenous insulin infusion increases health care costs. A recent study proposes using a subcutaneous fast-acting analog of human insulin ...

insulin conjugates with properties such as NNC2215 hold promise for improving treatment of diabetes by potentially lowering the risk of hypoglycemia and partly covering the need for fast-acting ...

providing a background level of blood glucose control that can sometimes be topped up at mealtimes with fast-acting insulins. The results of the ONWARDS 2 trial of insulin icodec showed that it ...

Wearable glucose monitors have become the latest health accessory, but are there benefits to tracking those spikes and dips?

Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller ...